Your Exit Plan Is Built on Today’s EBITDA. Should It Be?

SAI WHITE PAPER SERIES

Your Exit Plan Is Built on Today’s EBITDA. Should It Be?

How Exit Planning Advisors Can Distinguish Current Financial Performance From the Structural Conditions That May Be Limiting Pre-Sale Value

Lawrence M. Schneider
Founder & CEO, Schneider Axiom Institute™

PUBLICATION IDENTITY

Permanent Publication Identifier: SAI-ACPP-06
Original Publication: June 2026
Current Editorial Revision: September 2026
Version: 2.0
Classification: Exit Planning Advisors
Subject: Exit Planning, Pre-Sale Value & Structural Diagnosis
Primary Audience: Exit Planning Advisors
SAI Discipline Stage: IDENTIFY → PRIORITIZE
Evidence Orientation: Interpretive Proposition Supported by Valuation and M&A Research, Operating Observation, and Illustrative Scenarios

Executive Abstract

An exit plan often begins with the financial performance the business is producing now: revenue, margins, EBITDA, cash flow, debt, and working capital. Those numbers matter because they establish the business’s current financial condition and provide the baseline for much of the planning that follows.

But they may not tell the Exit Planning Advisor whether the business entering the preparation runway is already operating at the strongest condition it can reasonably achieve before sale.

A business may be producing current EBITDA while carrying customer concentration, owner dependence, weak management depth, inconsistent operating execution, poor earnings quality, or another structural condition that affects performance, transferability, resilience, or buyer perception. That does not mean a higher future EBITDA can be assumed, that resolving one condition will produce a particular valuation multiple, or that every structural improvement will be rewarded dollar-for-dollar at closing.

It means something narrower and more useful:

Today’s EBITDA is an observation of current performance. It should not automatically be treated as proof of the business’s best achievable pre-sale condition.

The Exit Planning Advisor therefore has two related but different questions to answer: What is the business producing now, and is a material structural condition limiting what the business could reasonably become before the transaction process begins?

Those questions belong together.

They are not the same question.

THE CENTRAL PROPOSITION

An exit plan built only on current financial performance may overlook structural conditions that are suppressing the business before the transaction process begins. A governing constraint may affect earnings quality, transferability, buyer perception, management dependence, concentration risk, or operating resilience. The Exit Planning Advisor’s task is not to assume a higher post-resolution value, but to determine whether a material business condition deserves attention before current EBITDA is treated as the fixed foundation of the exit plan.

That distinction protects the advisor from two opposite mistakes.

The first is assuming that current EBITDA is simply what the business is capable of producing and therefore should become the permanent foundation of the plan. The second is assuming that resolving a governing constraint makes a higher transaction value calculable before the operating improvement has actually occurred.

Neither conclusion is sufficiently disciplined.

Current financial performance is evidence. Future improvement is a hypothesis until achieved. Transaction value remains a market outcome.

Why This Paper Matters

Exit planning is unusually sensitive to sequence. Once a business enters the market, the owner’s ability to change structural conditions may become constrained by time, disclosure requirements, buyer expectations, diligence findings, and the transaction calendar.

Before the listing, the owner may have months or years in which to improve the business. After an LOI has been signed, much of that preparation runway has disappeared.

That creates a significant advisory question: If a structural condition is limiting performance, transferability, resilience, or buyer confidence, should the exit plan simply model the current business—or should the preparation runway first examine whether that condition can be improved?

Financial planning can optimize the consequences of the business that exists. It cannot, by itself, determine whether the business entering the transaction process is structurally ready for the result the owner expects.

The preparation runway is not merely time before the transaction. It is the last period in which the business itself may still be materially improved before buyers begin pricing what they see.

That does not justify promising a better outcome. It justifies diagnosing the business before assuming that today’s operating condition should become tomorrow’s transaction baseline.

Current EBITDA Is an Observation—not Necessarily the Business’s Best Achievable Pre-Sale Condition

EBITDA is important because it summarizes operating earnings before interest, taxes, depreciation, and amortization. But it is still a result. It does not explain why the business is producing that result.

A business earning $1 million of EBITDA may be operating efficiently and close to its reasonable pre-sale potential. Another business earning the same $1 million may be constrained by customer concentration, excessive owner dependence, poor operating discipline, volatile earnings, weak management independence, or another condition affecting performance quality.

The number can be identical while the condition behind it is materially different.

Current EBITDA describes performance. Diagnosis asks what is governing it.

That distinction should occur before the exit plan treats current performance as structurally fixed.

Three Possibilities Should Be Considered

Current Performance May Be Structurally Sound

The business may already be operating near the level reasonably supported by its market, assets, team, economics, and strategy. In that case, the Exit Planning Advisor should not invent an improvement thesis merely because more preparation time exists.

Current operating performance may be the appropriate planning baseline.

Current Performance May Be Suppressed by a Material Condition

A structural condition may be limiting revenue, margin, execution, management independence, cash conversion, or another operating result. If the condition can be identified and is realistically addressable within the preparation runway, it may deserve priority before the transaction process begins.

That does not make the post-resolution result knowable in advance.

It creates a reason to investigate.

Current EBITDA May Be Strong While Transaction Readiness Is Weak

A company can produce attractive EBITDA while carrying structural exposure that buyers may consider material. Customer concentration, owner dependence, unreliable earnings, weak management depth, cash-flow volatility, unusual working-capital requirements, or uncertainty around performance sustainability can all matter even when current profitability appears strong.

In that case, the principal issue may not be increasing EBITDA.

It may be improving the quality, transferability, resilience, or credibility of the earnings already being produced.

EBITDA and Business Quality Are Related—but They Are Not Identical

A business can improve operationally without immediately producing a higher transaction value. It can also improve transaction readiness without materially increasing EBITDA.

Consider a business that reduces excessive owner dependence. EBITDA may initially remain unchanged, but the business may become easier for a buyer to understand, operate, integrate, or finance.

A company that diversifies an unusually concentrated customer base may not immediately increase revenue, but the risk profile associated with one customer representing a disproportionate share of revenue may change. A company that improves the reliability and transparency of its earnings may report a similar accounting result while reducing uncertainty about what those earnings represent.

These distinctions matter because:

Transaction readiness is broader than current profitability.

What Research Adds to the Inquiry

External scholarship does not validate the Business Constraint Discipline™, the Seven Classes of Business Constraint™, or the proposition that every business is governed by one constraint.

It does support several narrower observations that matter to exit planning.

Research has found a positive association between earnings quality and firm valuation, suggesting that the quality and reliability of reported earnings can matter alongside the earnings number itself. [1] Research on takeover targets has also found that earnings quality can influence how bidders structure and evaluate acquisitions, particularly where information asymmetry is greater. [2]

Li and Tong found that greater target information uncertainty was associated with lower valuation multiples in their M&A sample. [3] Customer concentration also has documented transaction implications: Cheng, Jaggi, and Young found that acquirers placed fewer bids for targets with greater customer concentration and adjusted offer structure in response to concentration-related uncertainty. [4]

Other research has associated concentrated customer bases with higher financing risk and cost of capital under certain conditions. [5]

None of these findings establishes that a particular business has a governing constraint.

They support a narrower conclusion:

Buyers may care about the quality, concentration, uncertainty, durability, and transferability behind the financial result—not merely the result itself.

The Preparation Runway Creates an Option—not a Guaranteed Outcome

The preparation runway can create time to address a material condition, but time is not the same as certainty.

If an owner has three years before a planned exit, the advisor may have an opportunity to investigate customer concentration, management dependence, operational instability, margin leakage, working-capital pressure, market positioning, or another structural condition. The existence of time, however, does not guarantee that the condition can be fully resolved.

Nor does resolution guarantee that a buyer will assign a particular value to it.

The preparation runway creates an opportunity to improve the business before sale. It does not create a guaranteed transaction premium.

That distinction should remain explicit throughout the engagement.

Illustrative Scenario: The Customer Concentration Question

A business generates strong EBITDA, but one customer represents 42 percent of annual revenue. The owner views the concentration as evidence of a valuable long-term relationship. A potential buyer may view the same concentration as exposure.

Neither interpretation should be assumed automatically.

The Exit Planning Advisor’s task is to determine what the concentration means for this particular business.

Is the relationship contractually durable?

Is switching risk low or high?

Is customer bargaining power increasing?

Could the business replace the revenue?

Does the concentration constrain growth?

Would diversification strengthen the company even if total EBITDA remained unchanged?

The question is not:

“What discount will the buyer apply?”

That cannot be known in advance.

The better question is:

“Is this concentration a material structural condition that deserves attention before buyers evaluate the company?”

Illustrative Scenario: The Owner-Dependent Business

A company reports attractive EBITDA, but the owner personally controls the largest customer relationships, approves major operating decisions, resolves high-level employee conflicts, and carries institutional knowledge that has not been transferred to the management team.

The earnings are real.

The question is how transferable they are.

If the owner leaves, will the organization continue producing them?

That is not solely a valuation question. It is an operating question that should be examined before the business reaches due diligence.

If management independence can be strengthened during the preparation runway, the business entering the transaction may be structurally different from the business at the beginning of the exit plan.

The improvement strengthens the business. The market determines what that improvement is worth in a particular transaction.

Illustrative Scenario: EBITDA Improves During Preparation

An owner enters a three-year exit-planning engagement while the business is producing $900,000 of EBITDA. Diagnostic work suggests that an operational condition may be contributing to avoidable margin leakage.

The condition is addressed. Eighteen months later, EBITDA is $1.1 million.

At that point, the advisor has something materially different from the projection made at the beginning of the engagement: the business has actually produced the improvement. That observed result can now be incorporated into updated planning, valuation, and transaction-readiness analysis.

The advisor should still avoid saying:

“The constraint created $200,000 of EBITDA, therefore it created $1 million of transaction value at a five-times multiple.”

The improvement may have contributed materially, but transaction value will also depend on market multiples, earnings quality, growth expectations, buyer demand, financing, diligence, competitive tension, deal structure, and other conditions present at the time of sale.

Observed operating improvement is evidence. Transaction value remains a separate determination.

Improved Business Quality Does Not Equal Guaranteed Transaction Value

A stronger business may be more attractive to buyers. It may have more durable earnings, less owner dependence, greater customer diversification, stronger management, lower information uncertainty, or fewer obvious operating exposures.

Those improvements are commercially meaningful.

But they do not mechanically produce a premium.

Industry multiples may fall. Financing markets may tighten. Buyer strategy may change. A diligence issue may emerge elsewhere. Competitive tension may be limited. Different buyers may simply value the same improvement differently.

Business improvement and transaction value are connected. They are not mechanically interchangeable.

Buyer Compatibility Can Improve Without Guaranteeing Buyer Participation

Certain structural conditions may narrow the range of buyers willing to pursue a business. Customer concentration, owner dependence, management depth, earnings quality, business size, and industry risk can all influence buyer interest.

But resolving one condition does not automatically “open” a buyer category.

The more defensible questions are whether reducing the exposure makes the company compatible with a broader range of buyer requirements, whether stronger management independence reduces a concern some buyers may have, whether greater earnings clarity reduces information uncertainty, and whether customer diversification improves the company’s transaction profile.

Buyer compatibility can improve. Buyer participation and pricing remain uncertain.

Preparation Improves the Evidence. It Does Not Predetermine Due Diligence.

Due diligence exists to test the business. A well-prepared company may still produce unexpected findings.

Quality-of-earnings work may alter adjusted EBITDA. Working-capital requirements may change. Customer contracts may reveal exposure. Legal, tax, technology, operational, or regulatory issues may emerge.

Diagnostic preparation should therefore not be framed as a way to make due diligence validate the seller’s plan. Its more defensible purpose is to improve the quality of the business and the evidence buyers will eventually examine.

Preparation can reduce avoidable surprises. It cannot predetermine the buyer’s conclusion.

What the Exit Planning Advisor Should Distinguish

Four concepts should remain separate.

Current EBITDA

What the business is producing now.

Potential Operating Improvement

What management believes might improve if a material condition is corrected. Until achieved, this remains prospective.

Observed Post-Intervention Performance

What the business actually produces after corrective action. This can be measured.

Transaction Value

What a willing buyer ultimately agrees to pay under the conditions of the transaction.

These numbers may influence one another, but they are not the same number.

Confusing them turns disciplined exit planning into unsupported valuation storytelling.

The Seven Classes Organize the Inquiry

SAI organizes potential governing conditions into the Seven Classes of Business Constraint™:

Market · Operational · Financial · Organizational · Strategic · Leadership · Credibility

For an Exit Planning Advisor, these classes organize investigation. They do not determine valuation.

Customer concentration may indicate a Market question. Working-capital pressure may indicate a Financial question. Owner dependence may indicate a Leadership or Organizational question. Weak positioning may indicate a Strategic or Market question. Poor earnings credibility may raise a Credibility question.

But symptoms should not be classified automatically.

The class follows the evidence.

The transaction consequence, if any, must be evaluated separately.

One Governing Constraint Does Not Explain Every Element of Transaction Value

A business can have one governing constraint while its ultimate sale price reflects many variables. That is not a contradiction.

The governing constraint concerns what is currently limiting the business’s required performance. Transaction value is a market outcome incorporating broader considerations such as earnings, growth, risk, buyer competition, financing, industry conditions, strategic fit, synergies, deal structure, tax, working capital, capital expenditures, management, customer quality, and information uncertainty.

Therefore:

Identifying the governing constraint does not identify the transaction price.

It identifies the condition that deserves operating priority.

The Business Constraint Diagnostic™ Does Not Replace Valuation or Transaction Advice

The Business Constraint Diagnostic™ is not a business valuation, quality-of-earnings report, investment-banking opinion, fairness opinion, tax analysis, legal review, financial audit, buyer-selection process, or forecast of transaction proceeds.

It does not determine the multiple a buyer will pay. It does not determine adjusted EBITDA. It does not calculate a strategic premium. It does not predict whether an earnout will be required. And it does not establish that resolving a condition will expand the buyer pool.

Its role is narrower:

to examine the probable governing constraint class and the structural condition indicated by the information supplied.

The finding can then be considered alongside valuation work, financial analysis, tax planning, estate planning, legal review, quality-of-earnings analysis, and transaction advice.

What the Business Constraint Diagnostic™ Can Contribute

The Business Constraint Diagnostic™ costs $89, consists of 81 questions, typically requires about 30 minutes, and produces a 2,200+ word written finding within 72 hours.

The written finding addresses the probable governing constraint class, the structural condition indicated by the information supplied, why that condition appears limiting, why prior efforts failed, and the corrective direction suggested by the diagnosis.

For an Exit Planning Advisor, that finding can help answer a question financial preparation alone may not answer:

Is there a material business condition that deserves priority before the current operating result is treated as the fixed foundation of the exit plan?

It does not project resolved EBITDA, predict transaction value, determine the multiple a buyer will pay, or guarantee that resolving the identified condition will improve sale proceeds.

The Diagnostic informs the preparation priority. It does not determine the transaction outcome.

Guarantee: “If your written finding does not identify a clear, actionable governing constraint, your $89 will be refunded.”

A Better Exit-Planning Conversation

Instead of telling the owner:

“Your business is worth EBITDA multiplied by the market multiple.”

the advisor can say:

“This is the value range suggested by current financial performance and current market assumptions. Before we treat that operating condition as fixed, we should determine whether a material structural condition is limiting the business during the preparation runway.”

Instead of saying:

“Resolve this constraint and your business will be worth $2 million more.”

the advisor can say:

“If this condition can be materially improved, we can measure what actually changes in the business and then update the valuation assumptions from observed evidence.”

And instead of promising that a buyer will pay a premium once the issue is fixed, the advisor can make the more defensible statement:

“A stronger business may present differently to buyers, but the market will determine what that improvement is worth.”

That is more credible.

And more useful.

Questions That Improve the Exit Plan

Before current EBITDA becomes the plan’s permanent baseline, the advisor should ask:

What condition currently appears to be governing the business’s performance?

Is that condition realistically addressable within the available preparation runway?

Would improvement affect earnings, transferability, resilience, concentration, management independence, or information quality? How will we distinguish projected improvement from improvement that has actually been achieved and sustained?

Those questions do not replace valuation.

They improve what valuation eventually has to evaluate.

IDENTIFY → PRIORITIZE → RESOLVE → CONFIRM

The Business Constraint Discipline™ uses the sequence:

IDENTIFY → PRIORITIZE → RESOLVE → CONFIRM

Applied to exit planning, the sequence means identifying the material condition indicated by the evidence, prioritizing whether that condition deserves attention during the preparation runway, resolving it where practical without assuming the financial result in advance, and confirming what actually changed in operating performance or business quality after intervention.

Only then should the exit plan incorporate the observed result as evidence.

Do not capitalize a hypothetical improvement before the business has produced it.

What This Paper Does Not Claim

This paper does not claim that current EBITDA is an invalid foundation for exit planning, that every business can materially improve before sale, or that resolving a governing constraint will increase EBITDA.

It does not claim that EBITDA improvement automatically creates transaction value at the same multiple, that reducing customer concentration guarantees additional buyers, that stronger management eliminates earnouts, or that structural improvement creates a strategic buyer premium.

It does not claim that due diligence will validate the seller’s preparation. It does not claim that the Business Constraint Diagnostic™ replaces valuation, quality-of-earnings analysis, tax planning, legal advice, investment banking, or transaction expertise.

And it does not claim that the external valuation and M&A research cited here independently validates the Business Constraint Discipline™, the Seven Classes of Business Constraint™, or the governing-constraint proposition.

The proposition is narrower:

Before current financial performance becomes the fixed foundation of an exit plan, the advisor should determine whether a material structural condition deserves attention during the preparation runway.

Implications / Applications

Separate Current Performance From Future Potential

Current EBITDA is observed. Future improvement is prospective until achieved.

Diagnose Before Capitalizing Improvement

Do not multiply an assumed improvement by a multiple and present the result as transaction value.

Improve the Business Before Improving the Story

Structural preparation should change operating evidence—not merely transaction positioning.

Treat Buyer Response as Uncertain

A stronger business may improve buyer compatibility without guaranteeing buyer participation or pricing.

Distinguish Business Quality From Sale Price

Better earnings quality, diversification, management depth, and resilience matter even when their precise transaction value cannot be isolated.

Use the Preparation Runway Deliberately

The time before sale is the opportunity to investigate and, where practical, improve material structural conditions.

Revalue From Evidence

If performance changes and holds, update the exit plan using observed results rather than original assumptions.

Limitations and Questions for Further Examination

The scenarios in this paper are illustrative. They are not presented as verified SAI transaction histories.

The relationship between business improvement and transaction outcome is complex. Valuation and sale proceeds may be affected by industry conditions, buyer competition, financing markets, strategic fit, synergies, interest rates, tax, legal issues, diligence findings, deal structure, and other factors outside the governing constraint.

Much of the external literature cited involves public firms or transaction datasets that may not directly represent privately held lower-middle-market businesses. Those findings should therefore inform context rather than be treated as precise predictions for an individual privately held company.

Further examination should consider how structural improvements affect quality-of-earnings findings, buyer compatibility, management transferability, diligence uncertainty, and observed transaction outcomes across different categories of privately held businesses.

Conclusion

The exit plan needs a financial baseline. But the first available EBITDA number should not automatically become an unquestioned description of the business the owner will eventually sell.

The business may already be structurally ready. It may be operating below its reasonable potential. It may produce strong earnings while carrying risk that affects transferability or buyer confidence. Or the preparation runway may simply confirm that current performance is the appropriate baseline.

The advisor should not assume improvement. The owner should not assume a premium. The Diagnostic should not predict the transaction. And the valuation should not capitalize a result the business has not yet produced.

Current EBITDA tells you what the business is producing now. It does not, by itself, tell you whether the business entering the exit plan is the strongest business the owner can reasonably bring to market.

Find that out first. Determine what deserves priority. Improve what the evidence supports. Confirm what actually changed. Then value the business that exists.

That is diagnosis before prescription.

Evidence Boundary

This paper advances an SAI interpretive proposition informed by external research on earnings quality, information uncertainty, customer concentration, valuation, acquisition structure, Lawrence M. Schneider’s operating perspective, and illustrative exit-planning scenarios.

The paper does not establish that a governing constraint generally suppresses transaction value, that resolving a governing constraint increases EBITDA, or that observed EBITDA improvement will be rewarded at a particular valuation multiple.

The Seven Classes of Business Constraint™ remain Market, Operational, Financial, Organizational, Strategic, Leadership, and Credibility.

The scenarios are illustrative. They are not verified SAI transaction case histories and should not be interpreted as evidence that a particular constraint resolution caused a particular valuation or transaction outcome.

External scholarship supports the intellectual context concerning earnings quality, information uncertainty, customer concentration, and acquisition decisions. It does not independently validate the Business Constraint Discipline™, the Seven Classes of Business Constraint™, the governing-constraint proposition, or the Business Constraint Diagnostic™.

The Business Constraint Diagnostic™ is a business diagnostic instrument. It is not a valuation opinion, quality-of-earnings report, financial audit, fairness opinion, legal analysis, tax analysis, investment-banking recommendation, or prediction of transaction value. It does not replace qualified valuation, accounting, legal, tax, financial, or M&A advice.

References

[1] Gaio, C., & Raposo, C. (2011). Earnings Quality and Firm Valuation: International Evidence. Accounting & Finance, 51, 467–499. https://doi.org/10.1111/j.1467-629X.2010.00362.x

[2] Raman, K., Shivakumar, L., & Tamayo, A. (2013). Target’s earnings quality and bidders’ takeover decisions. Review of Accounting Studies, 18, 1050–1087. https://doi.org/10.1007/s11142-013-9224-0

[3] Li, L., & Tong, W. (2017). Information uncertainty and target valuation in mergers and acquisitions. Journal of Empirical Finance, 45, 84–107. https://doi.org/10.1016/j.jempfin.2017.09.009

[4] Cheng, M., Jaggi, J., & Young, S. (2021). Customer concentration of targets in mergers and acquisitions. Journal of Business Finance & Accounting. https://doi.org/10.1111/jbfa.12587

[5] Dhaliwal, D. S., Judd, J., Serfling, M., & Shaikh, S. (2016). Customer Concentration Risk and the Cost of Equity Capital. Journal of Accounting and Economics, 61, 23–48. https://doi.org/10.1016/j.jacceco.2015.03.005

Related SAI Resources

Business Constraint Diagnostic™

What Is a Business Constraint?

The Seven Classes of Business Constraint™

How the Seven Classes of Business Constraint™ Work Together

Why Diagnostic Credentials Matter

CAS — Certified Axiom Strategist

About the Author

Lawrence M. Schneider is the Founder and CEO of the Schneider Axiom Institute and the founder of U.S. Lock Corporation, now owned by The Home Depot. He brings more than five decades of CEO-level operating experience across manufacturing, distribution, land development, residential and commercial construction, franchising, and multi-entity businesses. He developed the Business Constraint Discipline™ to help owners, executives, and advisors identify what is limiting a business, determine what deserves priority, and confirm whether corrective action worked.

About the Schneider Axiom Institute

The Schneider Axiom Institute is an Institute for Business Constraints. Its work is organized around a disciplined premise: diagnosis should precede prescription. Through research, practitioner education, diagnostic instruments, and credentials, SAI develops the capability to identify, prioritize, resolve, and confirm the governing constraint.